Managing HK in HF: Navigating the Evolving Clinical Landscape - a podcast by ReachMD

CME credits: 0.25

Valid until: 17-11-2022

Claim your CME credit at https://reachmd.com/programs/cme/managing-hk-in-hf-navigating-the-evolving-clinical-landscape/13029/

There is a substantial gap between the guideline recommendations for treatment and the real-world prescribing patterns of RAASi therapy. This disconnect results in worse cardiorenal outcomes and higher mortality in patients receiving suboptimal dosing. This is particularly true in patients with CKD who develop hyperkalemia, which constitutes the major barrier to optimal therapy.

In this activity, Drs. Ferdinand and Metra discuss how best to manage comorbidities, optimize RAASi therapy, and improve the long-term care for our patients with heart failure.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD